Literature DB >> 11286643

Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians.

R A Hegele1.   

Abstract

The incidence of coronary heart disease (CHD) among aboriginal people in northern Ontario has tripled over the past 20 years. This is inextricably linked to the remarkably high prevalence of type 2 diabetes in these native communities. Approximately 40% of the Oji-Cree of northern Ontario have typical obesity-related type 2 diabetes, which represents a drastic increase from virtually unreportable levels 50 years ago. The Oji-Cree have a private mutation in the HNF1A gene, namely G319S, which is absent from other ethnic groups and aboriginal populations. The most compelling reasons that HNF1A S319 is a diabetes-susceptibility allele are its consistent statistical association with the presence and severity of diabetes. Also, HNF1A S319 has specificity and positive predictive values of 97% and 95%, respectively, for the development of diabetes in the Oji-Cree by 50 years of age. This makes the HNF1A G319S genotype the most specific predictive genetic test for diabetes in any human population. HNF1A S319 has all the attributes of a thrifty allele in the Oji-Cree. It is possible that the recent increase in CHD in the aboriginal people of northern Ontario is the result of the expression of diabetes susceptibility due to HNF1A S319 as a consequence of rapid changes in environment and lifestyle.

Entities:  

Mesh:

Year:  2001        PMID: 11286643     DOI: 10.1007/s11883-001-0064-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  24 in total

1.  Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.

Authors:  R A Hegele; H Cao; A J Hanley; B Zinman; S B Harris; C M Anderson
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

2.  Increasing rates of ischemic heart disease in the native population of Ontario, Canada.

Authors:  B R Shah; J E Hux; B Zinman
Journal:  Arch Intern Med       Date:  2000-06-26

3.  Hemochromatosis and diabetes mellitus.

Authors:  R A Hegele; S B Harris; B Zinman
Journal:  Ann Intern Med       Date:  1998-10-01       Impact factor: 25.391

4.  Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree, using 190 microsatellite markers.

Authors:  R A Hegele; F Sun; S B Harris; C Anderson; A J Hanley; B Zinman
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

5.  Type 2 (non-insulin dependent) diabetes in minority youth: conference report.

Authors:  R S Young; A L Rosenbloom
Journal:  Clin Pediatr (Phila)       Date:  1998-02       Impact factor: 1.168

6.  The prevalence of NIDDM and associated risk factors in native Canadians.

Authors:  S B Harris; J Gittelsohn; A Hanley; A Barnie; T M Wolever; J Gao; A Logan; B Zinman
Journal:  Diabetes Care       Date:  1997-02       Impact factor: 19.112

Review 7.  Health and development in the Hudson Bay/James Bay region.

Authors:  D Stieb; K Davies
Journal:  Arctic Med Res       Date:  1995-10

8.  Incidence and prevalence of diabetes in children aged 0-14 years in Manitoba, Canada, 1985-1993.

Authors:  J F Blanchard; H Dean; K Anderson; A Wajda; S Ludwig; N Depew
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 9.  Monogenic diabetes mellitus in youth. The MODY syndromes.

Authors:  W E Winter; M Nakamura; D V House
Journal:  Endocrinol Metab Clin North Am       Date:  1999-12       Impact factor: 4.741

10.  Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario.

Authors:  S B Harris; B A Perkins; E Whalen-Brough
Journal:  Can Fam Physician       Date:  1996-05       Impact factor: 3.275

View more
  3 in total

1.  Labrador tea (Rhododendron groenlandicum) attenuates insulin resistance in a diet-induced obesity mouse model.

Authors:  Meriem Ouchfoun; Hoda M Eid; Lina Musallam; Antoine Brault; Shilin Li; Diane Vallerand; John T Arnason; Pierre S Haddad
Journal:  Eur J Nutr       Date:  2015-04-28       Impact factor: 5.614

2.  Larix laricina, an Antidiabetic Alternative Treatment from the Cree of Northern Quebec Pharmacopoeia, Decreases Glycemia and Improves Insulin Sensitivity In Vivo.

Authors:  Despina Harbilas; Diane Vallerand; Antoine Brault; Ammar Saleem; John T Arnason; Lina Musallam; Pierre S Haddad
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-19       Impact factor: 2.629

3.  A new susceptibility locus for myocardial infarction, hypertension, type 2 diabetes mellitus, and dyslipidemia on chromosome 12q24.

Authors:  Salma M Wakil; Nzioka P Muiya; Asma I Tahir; Mohammed Al-Najai; Batoul Baz; Editha Andres; Nejat Mazhar; Nada Al Tassan; Maie Alshahid; Brian F Meyer; Nduna Dzimiri
Journal:  Dis Markers       Date:  2014-06-26       Impact factor: 3.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.